Biopharmaceutics & Drug disPosition

Papers
(The median citation count of Biopharmaceutics & Drug disPosition is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
35
In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit’s intestine29
Evaluation of bottom‐up modeling of the blood–brain barrier to improve brain penetration prediction via physiologically based pharmacokinetic modeling21
Aging and brain free cholesterol concentration on amyloid‐β peptide accumulation in guinea pigs18
Decreased plasma acetaminophen glucuronide/acetaminophen concentration ratio warns the onset of acetaminophen‐induced liver injury17
Issue Information15
Self‐micellizing solid dispersion of tacrolimus: Physicochemical and pharmacokinetic characterization13
Issue Information10
10
Evaluating gender effect in the generic bioequivalence studies by physiologically based pharmacokinetic modeling – A case study of dextromethorphan modified release tablets10
Evaluation of sex differences in the pharmacokinetics of oral sumatriptan in healthy Korean subjects using population pharmacokinetic modeling10
Issue Information9
Issue Information9
Issue Information9
Issue Information8
Utility of cystatin C and serum creatinine‐based glomerular filtration rate equations in predicting vancomycin clearance: A population pharmacokinetics analysis in elderly Chinese patients8
Evidence for cytochrome P450 3A4‐mediated metabolic activation of SCO‐2678
Estimation of fraction of drug metabolism by a single UDP‐glucuronosyl transferase enzyme using relative expression factor7
Novel Enteric Microsphere of Beclomethasone Dipropionate With Colon Delivery and Enhancement of Anti‐Inflammatory Effects7
Attenuation of phenobarbital‐induced cytochrome P450 expression in carbon tetrachloride‐induced hepatitis in mice models7
Metabolism and pharmacokinetic study of deuterated osimertinib7
Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells6
Norvancomycin plasma concentration monitoring in hemodialysis patients with end stage kidney disease: A retrospective cohort study6
Issue Information6
Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3‐selective GABAkine KRM‐II‐816
Irinotecan‐induced gastrointestinal damage alters the expression of peptide transporter 1 and absorption of cephalexin in rats6
The Role of Nasal Drug Delivery in Migraine Management and Brain‐Targeted Therapy: Insights From Taiwan6
Enhanced Vatiquinone Bioavailability With Fatty Meals and Optimal Dosing Schedule6
Pharmacokinetic control of orally dosed cyclosporine A with mucosal drug delivery system5
Integration of artificial neural network and physiologically based biopharmaceutic models in the development of sustained‐release formulations5
Species Differences in Carboxylesterases Among Humans, Cynomolgus Monkeys, and Mice in the Hydrolysis of Atorvastatin Derivatives5
Predicting transporter mediated drug–drug interactions via static and dynamic physiologically based pharmacokinetic modeling: A comprehensive insight on where we are now and the way forward5
5
Intestinal absorption pathways of lisinopril: Mechanistic investigations5
Issue Information4
Involvement of SLC16A1/MCT1 and SLC16A3/MCT4 in l‐lactate transport in the hepatocellular carcinoma cell line4
Contribution of Organic Anion Transporter 3 in Delayed Elimination of Methotrexate by Concomitant Administration of Febuxostat4
Identification and characterization of an endogenous biomarker of the renal vectorial transport (OCT2‐MATE1)4
Comparative Study on Cannabidiol‐Loaded Solubilizing Systems for Improvement of Oral Bioavailability: Liposome and Cyclodextrin‐Based Formulations4
4
4
Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds4
Prediction of basic drug exposure in milk using a lactation model algorithm integrated within a physiologically based pharmacokinetic model4
4
3
Metabolism of testosterone and progesterone by cytochrome P450 2C19 allelic variants2
Issue Information2
2
In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery2
2
Characterization of AST‐001 non‐clinical pharmacokinetics: A novel selective AKR1C3‐activated prodrug in mice, rats, and cynomolgus monkeys2
In vitro and in silico interactions of antiulcer, glucocorticoids and urological drugs on human carbonic anhydrase I and II isozymes2
2
2
Icaritin exhibits potential drug–drug interactions through the inhibition of human UDP‐glucuronosyltransferase in vitro2
Influence of piperine and omeprazole on the regional absorption of Daclatasvir from rabbit intestine2
Gender difference in the pharmacokinetics and metabolism of VX‐548 in rats2
Pregnenolone Sulfate Permeation at the Blood–Brain Barrier is Independent of OATP2B1—In Vivo and In Vitro Insights1
Evaluation of bleeding and anticoagulation markers by edoxaban and low‐dose cyclosporine: A case series study1
In vivo monitoring of brain pharmacokinetics and pharmacodynamics with cerebral open flow microperfusion1
An Optimised Mobilenet V2 Attention Parallel Network for Predicting Drug–Drug Interactions Through Combining Local and Global Features1
Pharmacokinetic–pharmacodynamic modeling of the active components of Shenkang injection in rats with chronic renal failure and its protective effect on damaged renal cells1
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry1
Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk1
Issue Information1
The Effect of α ‐Mangostin on the Pharmacokinetic Profile of Tofacitinib in Rats Both In Vitro and In Vivo1
1
Across‐Species Meta‐Analysis of Betamethasone Pharmacokinetics Utilizing a Minimal PBPK Model1
Optimizing transcardial perfusion of small molecules and biologics for brain penetration and biodistribution studies in rodents1
1
Effect of hepar‐protecting Wuzhi capsule on pharmacokinetics and dose‐effect character of tacrolimus in healthy volunteers1
1
0.20062398910522